From the publishers of JADPRO

Multiple Myeloma Resource Center

Advertisement
Case Studies
Treatment of Intermediate Risk Smoldering Myeloma
Patient Newly Diagnosed With MM and Ineligible for SCT With Relapse on Anti-CD38 and Lenalidomide-Based Therapy
Treatment of Newly Diagnosed Multiple Myeloma
Single Solitary Plasmacytoma to Active Myeloma
First Relapse of Multiple Myeloma Patient
A Heavily Treated Relapsed/Refractory Multiple Myeloma Patient on Talquetamab
Treatment of Relapsed Multiple Myeloma With Bispecific Antibodies
Early Relapsed Multiple Myeloma With Translocation (11;14)
Advertisement
Case Studies

Treatment of Intermediate Risk Smoldering Myeloma

Patient Newly Diagnosed With MM and Ineligible for SCT With Relapse on Anti-CD38 and Lenalidomide-Based Therapy

Single Solitary Plasmacytoma to Active Myeloma

Advertisement
Quizzes
Test your knowledge on intermediate risk smoldering multiple myeloma
Test your knowledge on managing a patient newly diagnosed with MM and ineligible for stem-cell transplant
Test your knowledge of newly diagnosed multiple myeloma